Related Experiment Video
Updated: Aug 7, 2026

Dissociation of Human and Mouse Tumor Tissue Samples for Single-cell RNA Sequencing
Published on: August 16, 2024
Immunological strategies to fight skin cancer
1Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, USA.
Abstract:
Skin cancer is the most common human cancer, and is currently considered a global epidemic. Recently, there has been a growing interest in immunomodulators, or up-regulators of the immune response, for the treatment and cure of various forms of skin cancer, including melanoma and nonmelanoma skin cancers, cutaneous T-cell lymphoma, Kaposi's sarcoma, cutaneous extramammary Paget's disease, and vulvar intraepithelial carcinoma neoplasia. Strategies to augment the host's immune response against cancer cells and/or cancer cell antigenicity have been investigated, including recombinant cytokines, immunomodulators, dendritic cell immunization, tumor antigen vaccination, T-cell-based immunotherapy, and gene therapy. Although the current standard of care for most of these cancers includes Mohs micrographic surgery, curettage, and cryo-, laser-, or radiotherapy, immunomodulators are becoming essential in the treatment of patients who are poor surgical candidates and/or require noninvasive therapy.
Insights
Immunomodulators are increasingly vital for treating skin cancers like melanoma. These therapies boost the immune system, offering noninvasive options for patients unsuitable for surgery.
Area of Science:
- Oncology
- Immunology
Background:
- Skin cancer represents a global epidemic and the most common human cancer.
- There is a growing interest in immunomodulators for treating various skin cancers, including melanoma and nonmelanoma types.
Purpose of the Study:
- To explore the role of immunomodulators in treating diverse skin cancers.
- To review strategies for augmenting the host immune response against cancer cells.
Main Methods:
- Investigated strategies include recombinant cytokines, immunomodulators, dendritic cell immunization, tumor antigen vaccination, T-cell-based immunotherapy, and gene therapy.
- Reviewed current standard treatments such as Mohs surgery, curettage, and radiotherapy.
Main Results:
- Immunomodulators are emerging as essential treatments for specific skin cancers.
- These therapies offer noninvasive alternatives for patients who are poor surgical candidates.
Conclusions:
- Immunomodulators represent a significant advancement in skin cancer treatment.
- They provide crucial therapeutic options, particularly for patients requiring noninvasive approaches.
Related Concept Videos
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cell-mediated Immune Responses

